BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition

  December 10, 2024

   · 

  14 min read
• Press Releases

  Wyss Center for Bio and Neuroengineering Announces Venture with dEEGtal Insight: An Innovative Tool for Early Epilepsy Detection

  December 10, 2024

   · 

  2 min read
• Press Releases

  CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines

  December 10, 2024

   · 

  4 min read
• Press Releases

  Merakris Therapeutics Announces Open Enrollment for Phase II Clinical Trial of Subcutaneous Injection Drug for the Treatment of Venous Leg Ulcer

  December 10, 2024

   · 

  4 min read
• Press Releases

  Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium

  December 10, 2024

   · 

  10 min read
• Press Releases

  Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

  December 10, 2024

   · 

  17 min read
• Press Releases

  Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients

  December 10, 2024

   · 

  17 min read
• Press Releases

  LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 9, 2024

  December 10, 2024

   · 

  1 min read
• Press Releases

  Kite’s Yescarta® Only CAR T-Cell Therapy to Show Durable Response and Long-Term Survival After Five Years in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas at ASH 2024

  December 10, 2024

   · 

  18 min read
• Press Releases

  Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 9, 2024

  December 10, 2024

   · 

  2 min read